LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 19

Search options

  1. Article ; Online: Reply.

    Massoumi, Hatef

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

    2021  Volume 27, Issue 9, Page(s) 1360

    Language English
    Publishing date 2021-06-29
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2006866-9
    ISSN 1527-6473 ; 1527-6465
    ISSN (online) 1527-6473
    ISSN 1527-6465
    DOI 10.1002/lt.25915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Granulocyte colony-stimulating factor does not improve mortality in severe alcoholic hepatitis: a single-center experience from the United States.

    Nahas, Jonathan / Tow, Clara Y / Chacko, Kristina R / Haider, Tehseen / Massoumi, Hatef

    Gastroenterology and hepatology from bed to bench

    2023  Volume 16, Issue 1, Page(s) 524–526

    Abstract: Aim: To assess the role of granulocyte colony-stimulating factor (GCSF) in the patients with severe alcoholic hepatitis (SAH) using real world experience in the United States.: Background: There are few effective treatments for severe alcoholic ... ...

    Abstract Aim: To assess the role of granulocyte colony-stimulating factor (GCSF) in the patients with severe alcoholic hepatitis (SAH) using real world experience in the United States.
    Background: There are few effective treatments for severe alcoholic hepatitis, which has a significant fatality rate. GCSF has been associated with improved survival in a small number of Indian studies, while there is a dearth of information from other parts of the globe.
    Methods: We performed a single-center retrospective study of consecutive patients admitted to a tertiary care, liver transplant center with severe alcoholic hepatitis from May 2015 to February 2019. The patients receiving GCSF (5μg/kg subcutaneously every 12 hours for 5 consecutive days) (n=12) were compared to the patients receiving standard of care (n=42).
    Results: Thirty-day, 90-day and 1-year mortality rates was similar among groups (25% vs. 17%, P=0.58; 41% vs 29%, P=0.30; 41% vs 47%, P=0.44, respectively). There was no difference in liver transplant listing and orthotopic transplantation among groups.
    Conclusion: In this real-world, United States-based study, GCSF does not improved survival in the patient with several alcoholic hepatitis compared to standard of care.
    Language English
    Publishing date 2023-04-13
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2569124-7
    ISSN 2008-4234 ; 2008-2258
    ISSN (online) 2008-4234
    ISSN 2008-2258
    DOI 10.22037/ghfbb.v16i1.2639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center-Level Variability.

    Massoumi, Hatef / Rocca, Juan / Frager, Shalom / Kinkhabwala, Milan

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

    2020  Volume 26, Issue 9, Page(s) 1198–1199

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus ; Coronavirus Infections ; Humans ; Liver Transplantation ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-07-16
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2006866-9
    ISSN 1527-6473 ; 1527-6465
    ISSN (online) 1527-6473
    ISSN 1527-6465
    DOI 10.1002/lt.25811
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Changes in Liver Transplant Center Practice in Response to Coronavirus Disease 2019: Unmasking Dramatic Center-Level Variability

    Massoumi, Hatef / Rocca, Juan / Frager, Shalom / Kinkhabwala, Milan

    Liver Transpl

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #740853
    Database COVID19

    Kategorien

  5. Article: COVID-19 Infection in Early Post-Operative Period after Liver Transplantation

    Massoumi, Hatef / Rocca, Juan / Frager, Shalom / Kinkhabwala, Milan

    Liver transpl

    Abstract: We read the recently published article by Drs. Agopian, Verna and Goldberg (1) with great interest. The authors have provided an important assessment of liver transplant volumes across the United Network for Organ Sharing (UNOS) regions from February to ... ...

    Abstract We read the recently published article by Drs. Agopian, Verna and Goldberg (1) with great interest. The authors have provided an important assessment of liver transplant volumes across the United Network for Organ Sharing (UNOS) regions from February to March of 2019 and 2020. The study revealed a significant center-based difference in volume of transplant particularly among centers located in the same metropolitan areas including New York City.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32502316
    Database COVID19

    Kategorien

  6. Article ; Online: Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.

    Frager, Shalom Z / Szymanski, James / Schwartz, Jonathan M / Massoumi, Hatef S / Kinkhabwala, Milan / Wolkoff, Allan W

    Hepatology communications

    2020  Volume 5, Issue 3, Page(s) 424–433

    Abstract: The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the causative agent of coronavirus disease 2019 (COVID-19). The presenting symptoms of this virus are variable, and there is an increasing body of literature on risk ... ...

    Abstract The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the causative agent of coronavirus disease 2019 (COVID-19). The presenting symptoms of this virus are variable, and there is an increasing body of literature on risk factors for mortality. The aim of this study was to evaluate the effect of initial aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and preexisting liver disease, including cirrhosis, in a cohort of patients admitted with COVID-19 infection at a tertiary care hospital network in the Bronx, New York. We reviewed 3,352 patients who had a positive SARS-CoV2 nasal swab, were over 18 years of age, and had an associated inpatient admission and discharge (or death) to the Montefiore Medical Center from February 28, 2020, to May 22, 2020. Of these, 39/86 (45%) patients died when the initial ALT was >5 times the upper limit of normal (ULN); 115/230 (50%) patients died when the initial AST was >3 times the ULN. The mortality of patients without preexisting liver disease was 26.6% compared to a mortality rate of 29.5% in patients with liver disease. Subgroup analysis showed a mortality of 36.1% in the patients with cirrhosis. Cirrhosis conferred a hazard ratio for mortality of 1.67 (95% confidence interval, 1.09, 2.55;
    MeSH term(s) Aged ; Aged, 80 and over ; Alanine Transaminase/analysis ; Aspartate Aminotransferases/analysis ; COVID-19/diagnosis ; COVID-19/mortality ; Cohort Studies ; Female ; Hospitalization ; Humans ; Liver/physiopathology ; Liver/virology ; Liver Cirrhosis/complications ; Male ; Middle Aged ; New York ; Prognosis ; Respiratory Insufficiency ; Risk Factors ; Severity of Illness Index ; Survival Analysis ; Tertiary Care Centers
    Chemical Substances Aspartate Aminotransferases (EC 2.6.1.1) ; Alanine Transaminase (EC 2.6.1.2)
    Language English
    Publishing date 2020-12-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2471-254X
    ISSN (online) 2471-254X
    DOI 10.1002/hep4.1648
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Clinical characteristics and response to therapy of autoimmune hepatitis in an urban Latino population.

    Zahiruddin, Ayesha / Farahmand, Abtin / Gaglio, Paul / Massoumi, Hatef

    Gastroenterology and hepatology from bed to bench

    2016  Volume 9, Issue 3, Page(s) 225–230

    Abstract: Aim: We hypothesized that AIH outcomes might be different in our patient population that consists of a large number of Latinos.: Background: Literature has suggested that the presentation and outcome of autoimmune hepatitis can be different among ... ...

    Abstract Aim: We hypothesized that AIH outcomes might be different in our patient population that consists of a large number of Latinos.
    Background: Literature has suggested that the presentation and outcome of autoimmune hepatitis can be different among different ethnicity and communities.
    Patients and methods: We performed a retrospective chart review of Latino patients with AIH diagnosed between 2002-2012. Complete and partial remissions were defined as normalization of liver enzyme values, or achieving less than twice the upper limit normal (ULN), respectively.
    Results: A total of 28 patients were identified. 26 (93%) were female. 13 (46%) had an acute presentation, one with type 2 AIH and 3 with ANA seronegative disease. The average pathologic stage (Ishak score) was 3.44±1.67 (range: 0-6). Complete and partial remission was achieved in 20 (71%) and 5 (18%) patients respectively. Ten patients (38%) required maintenance prednisone either alone (2), or in combination with Azathioprine (6) or Mycophenolate Mofetil (2). Remission in the majority of patients, including 14 (50%) who were cirrhotic. Six of 14 (43%) cirrhotic patients were asymptomatic at the time of diagnosis.
    Conclusion: In an urban Latino population, cirrhosis was the initial presentation of AIH in a significant percentage of patients raising concerns regarding insufficient screening for AIH in this patient population. A large number of patients required continuous prednisone to avoid relapse.
    Language English
    Publishing date 2016-03-17
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2569124-7
    ISSN 2008-4234 ; 2008-2258
    ISSN (online) 2008-4234
    ISSN 2008-2258
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Portal hypertensive vaginal bleeding.

    Harnik, Ian / Golowa, Yosef / Massoumi, Hatef

    Hepatology (Baltimore, Md.)

    2013  Volume 57, Issue 5, Page(s) 2085–2086

    MeSH term(s) Adult ; Female ; Humans ; Hypertension, Portal/complications ; Hypertension, Portal/diagnosis ; Portasystemic Shunt, Transjugular Intrahepatic ; Splenic Vein/diagnostic imaging ; Splenic Vein/surgery ; Stents ; Thrombectomy ; Thrombosis/complications ; Thrombosis/diagnostic imaging ; Thrombosis/surgery ; Tomography, X-Ray Computed ; Treatment Outcome ; Uterine Hemorrhage/diagnosis ; Uterine Hemorrhage/etiology
    Language English
    Publishing date 2013-05
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.26341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Ibrutinib-induced severe liver injury.

    Nandikolla, Amara G / Derman, Olga / Nautsch, Deborah / Liu, Qiang / Massoumi, Hatef / Venugopal, Sangeetha / Braunschweig, Ira / Janakiram, Murali

    Clinical case reports

    2017  Volume 5, Issue 6, Page(s) 735–738

    Abstract: Ibrutinib, an inhibitor of the Bruton's tyrosine kinase of the B-cell receptor pathway, is an effective therapeutic agent for B-cell lymphomas. As these drugs are novel, long-term or rare adverse events are not yet known. We report the first case of ... ...

    Abstract Ibrutinib, an inhibitor of the Bruton's tyrosine kinase of the B-cell receptor pathway, is an effective therapeutic agent for B-cell lymphomas. As these drugs are novel, long-term or rare adverse events are not yet known. We report the first case of ibrutinib-induced severe liver injury in a patient with relapsed/refractory CLL.
    Language English
    Publishing date 2017-03-15
    Publishing country England
    Document type Case Reports
    ZDB-ID 2740234-4
    ISSN 2050-0904
    ISSN 2050-0904
    DOI 10.1002/ccr3.881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Blue rubber bleb nevus syndrome.

    Massoumi, Hatef / Patel, Sharad

    Gastrointestinal endoscopy

    2007  Volume 65, Issue 7, Page(s) 1076; discussion 1077

    MeSH term(s) Adult ; Diagnosis, Differential ; Follow-Up Studies ; Gastrointestinal Hemorrhage/diagnosis ; Gastrointestinal Hemorrhage/etiology ; Gastrointestinal Neoplasms/complications ; Gastrointestinal Neoplasms/diagnosis ; Gastroscopy ; Hemangioma/complications ; Hemangioma/diagnosis ; Humans ; Male ; Nevus, Blue/complications ; Nevus, Blue/diagnosis ; Skin Neoplasms/complications ; Skin Neoplasms/diagnosis ; Syndrome
    Language English
    Publishing date 2007-06
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 391583-9
    ISSN 1097-6779 ; 0016-5107
    ISSN (online) 1097-6779
    ISSN 0016-5107
    DOI 10.1016/j.gie.2006.06.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top